For its second fiscal quarter (ending June 30), CrossAmerica Partners LP (NYSE: CAPL) has reported a -16% decline in E.P.S. from $0.37 a year ago to $0.31 in the current quarter. For the latest four […]
On 8/7/24, Climb Global Solutions Inc (NASDAQ: CLMB) stock enjoyed a major increase of 13.0%, closing at $73.54. Moreover, exceptionally high trading volume at 209% of normal accompanied the advance. The stock has risen 5.0% […]
Clearwater Paper Corp (NYSE: CLW) stock suffered a major decline of -20.9% on 8/7/24. The shares closed at $38.16. Moreover, this decline was accompanied by exceptionally high trading volume at 369% of normal. Relative to […]
Capricor Therapeutics Inc (NASDAQ: CAPR) has reported a loss for its second fiscal quarter (ending June 30) of $-0.35 versus a loss $-0.29 for the same period a year ago. This result fell short of […]
CVS Health Corp (NYSE: CVS) has reported earnings for its second fiscal quarter (ending June 30) of $1.41 versus $1.48 for the same period a year ago — a decline of -5%. This result fell […]
CACI International Inc (NYSE: CACI) has reported E.P.S. of $6.04 for its fourth fiscal quarter (ending June 30) versus $4.73 for the same period a year ago — an increase of 28%. Relative to the […]
For its second fiscal quarter (ending June 30), Avista Corp (NYSE: AVA) has reported a 26% increase in E.P.S. from $0.23 a year ago to $0.29 in the current quarter. However, this performance was $-0.00 […]
For its second fiscal quarter (ending June 30), Associated Capital Group Inc (NYSE: AC) has reported a -7% decline in E.P.S. from $0.15 a year ago to $0.14 in the current quarter. For the latest […]
eHealth Inc (NASDAQ: EHTH) stock closed at $3.83 on 8/7/24 after a major decline of -18.0%. Moreover, trading volume in this decline was exceptionally high at 273% of normal. The stock has declined -29.2% during […]
Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported E.P.S. of $1.18 for its second fiscal quarter (ending June 30) versus $1.00 for the same period a year ago — an increase of 18%. Relative to […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research